Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

CrossRef

Works that cite this article, indexed by Crossref.

20 resultsUpdated October 25, 2026

← Back to article

Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights

World Journal of Hepatology 7(14) (2015)

Maria Tampaki

Serum Serotonin as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Journal of Interferon & Cytokine Research 39(12) (2019)

Fatma Mamdouh; Shereen Abdel Alem; Mahmoud Abdo; Amaal Abdelaal; Amel Salem; Ahmed Rabiee; Ola Elsisi

Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study

Cancer Biomarkers 18(3) (2017)

Guo-Jian Li; Qin-Yan Chen; Tim J. Harrison; Xue-Yan Wang; Li-Ping Hu; Qing-Li Yang; Kai-Wen Li; Zhong-Liao Fang

The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?

Journal of Surgical Oncology 110(4) (2014)

Sameer A. Dhayat; Wolf A. Mardin; Gabriele Köhler; Ralf Bahde; Thorsten Vowinkel; Heiner Wolters; Norbert Senninger; Jörg Haier; Soeren T. Mees

Influence of Alanine Transaminase Levels on Alpha‐Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection

BioMed Research International 2020(1) (2020)

Jiahao Chen; Manli Wu; Jiao Gong; Zhihuan Liu; Guowei He; Huiqing Zhu; Zhaoxia Li; Bo Hu; Muhammad Hassham Hassan Bin Asad

Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century

Hepatitis Monthly 13(2) (2013)

Behzad Yeganeh; Mohammad Hashemi; Fredrick J. de Serres; Marek J. Los; Saeid Ghavami

Evaluation of the diagnostic value of alpha‐l‐fucosidase, alpha‐fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma

FEBS Open Bio 5(1) (2015)

Shi-Yan Zhang; Bi-Ding Lin; Bu-Ren Li

Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma

Biochemical and Biophysical Research Communications 497(4) (2018)

Hyosun Tak; Hoin Kang; Eunbyul Ji; Youlim Hong; Wook Kim; Eun Kyung Lee

Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2

The International Journal of Biochemistry & Cell Biology 89 (2017)

Wei Dai; Jian Wu; Shuyan Zhang; Bingjie Shi; Xinhui Xu; Danyang Wang; Jinke Wang

A Preclinical Study on 4-Methyl-N-((4-(trifluoromethoxy)phenyl) carbamoyl)-benzenesulfonamide as a Potent Chemotherapeutic Agent against Liver and Pancreatic Carcinogenesis in Rats: Immunohistochemical and Histopathological Studies

Medicinal Chemistry 21(7) (2025)

Farid M. Sroor; Eman A. Younis; Hanan F. Aly

Biomarkers as Drivers of Innovation in Modern Diagnostics and Therapeutics

Current Drug Targets 27(7) (2026)

Sakshi Soni; Sunny Rathee; Sanjay K. Jain

Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature

Oncology Letters 9(2) (2015)

HUAN-YU WANG; LIANG ZHANG; JIAN WU; ZI-JIAN ZHANG; BAO-GANG PENG; LI-JIAN LIANG; QI ZHOU

Hepatocellular carcinoma: Review of disease and tumor biomarkers

World Journal of Hepatology 8(10) (2016)

Jin Un Kim; Mohamed I F Shariff; Mary M E Crossey; Maria Gomez-Romero; Elaine Holmes; I Jane Cox; Haddy K S Fye; Ramou Njie; Simon D Taylor-Robinson

Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation

Molecular BioSystems 10(2) (2013)

Yanqiong Zhang; Xiaodong Guo; Mei Yang; Lingxiang Yu; Zhiwei Li; Na Lin